Novel Coronavirus (SARS-CoV-2/COVID-19)
In this conversation, Elisa Arespacochaga, Interim Executive Lead, Institute for Diversity & Health Equity and Vice President, AHA Physician Alliance, talks with Andrea Custis, President and CEO, Urban League of Philadelphia, about health inequities in Black and underserved communities with a…
As Congress continues to negotiate a year-end spending package and more COVID-19 relief, we’re continuing to keep you updated on the latest issues. This is our third Action Alert related to the lame-duck session, and information and resources related to our priority issues are included below.
The Centers for Medicare & Medicaid Services updated its guidance on enforcement discretion during the COVID-19 public health emergency for laboratories performing molecular and antigen tests for the virus on asymptomatic individuals at the point of care or in patient care settings operating…
Over 9,000 eligible nursing homes, or 69%, will receive a portion of $523 million in COVID-19 Provider Relief Funds for meeting infection control and mortality criteria in effect from September through October, the Health Resources and Services Administration announced.
The Department of Health and Human Services has released hospital-level data on COVID-19 capacity, aggregated by week going back to Aug. 1.
The Centers for Medicare & Medicaid Services Dec. 9 at 4 p.m. ET will host a call to discuss recent flexibilities the agency announced to allow acute health care services to be provided outside of a hospital setting in response to the surging COVID-19 pandemic.
New edition of COVID-19 Snapshot paints difficult picture for hospitals scrambling for pandemic help
The AHA released a new edition of the COVID-19 Snapshot to impart upon Congress the critical needs of hospitals and health systems during the deepening public health emergency.
The Food and Drug Administration released a briefing document on Pfizer’s BNT162b2 COVID-19 vaccine candidate that confirms the drug maker’s claims of the vaccine’s efficacy and safety.
The Centers for Disease Control and Prevention has published an addenda with instructions for implementing six new ICD-10 diagnosis codes for reporting COVID-19-related conditions on health care claims effective Jan. 1.
The Food and Drug Administration authorized the first prescription diagnostic test for both COVID-19 and influenza A and B that allows patients to collect a sample at home and ship it to a laboratory for analysis.